Delivery Order SPE2DB20D1004-SPE2DB25FNKBE
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $1,597.14 and an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,537.17 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,448.81 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections with a ceiling value of $4,416.68. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive set-aside arrangement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $5,441.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections (0.5 ml). This is a non-set-aside competitive award with an ultimate completion date of September 29, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a $1,040.19 delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This is a firm fixed-price contract with an ultimate completion date of September 26, 2025, and represents performance at the company's Conshohocken, Pennsylvania headquarters. The award was competitively procured with no set-aside designation and serves as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,225.01 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injections on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKBEDelivery Order
AmerisourceBergen Drug Corp received a $1,088.36 firm fixed price delivery order from the Defense Logistics Agency (DLA) on August 12, 2025, for supply of Mounjaro 7.5 mg/0.5 mL pen injections. The order, which is expected to be completed by August 13, 2025, was awarded on a competitive basis with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive portfolio of contract awards supporting military and veteran healthcare systems. The company's IDC with DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Mounjaro, an injectable diabetes medication, exemplifies the company's role in supplying essential pharmaceutical commodities to support Defense Health Agency and other federal healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/12/25 |